RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+17.86%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$345M
AUM Growth
+$345M
(+5.6%)
Cap. Flow
-$27.3M
Cap. Flow
% of AUM
-7.92%
Top 10 Holdings %
Top 10 Hldgs %
30.53%
Holding
110
New
11
Increased
34
Reduced
36
Closed
25
Top Buys
| 1 |
Gilead Sciences
GILD
|
$12.6M |
| 2 |
CELG
Celgene Corp
CELG
|
$11.4M |
| 3 |
Universal Technical Institute
UTI
|
$6.79M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$6.44M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$3.9M |
Top Sells
| 1 |
Universal Health Services
UHS
|
$10.3M |
| 2 |
Alkermes
ALKS
|
$7.2M |
| 3 |
Medtronic
MDT
|
$7.13M |
| 4 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
$4.83M |
| 5 |
Incyte
INCY
|
$4.61M |
Sector Composition
| 1 | Healthcare | 80.57% |
| 2 | Consumer Staples | 1.97% |
| 3 | Financials | 1.39% |